MindwaysCT receives FDA clearance for bone mineral density measurement technology

MindwaysCT received 510(k) clearance from the U.S. Food and Drug Administration to market its quantitative computed tomography calibration technology for CT-based bone mineral density measurement.

Advertisement

MindwaysCT’s latest QCT software innovation makes it possible to assess bone mineral density using QCT without the need to scan a calibration phantom together with the patient. The new technology can also offer retrospective analysis of previously acquired images.

More articles on devices:

aap Implantate receives patent for LOQTEQ
NuVasive COO sells 2.5k shares in $87k transaction
$0.9B by 2019: 3D printing in medical applications market analysis

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.